止血弁の世界市場予測（～2023年）...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 12
1.1 OBJECTIVES OF THE STUDY 12
1.2 MARKET DEFINITION 12
1.2.1 MARKETS COVERED 13
1.2.2 COUNTRY COVERAGE 13
1.2.3 YEARS CONSIDERED FOR THE STUDY 14
1.3 CURRENCY 14
1.4 LIMITATIONS 14
1.5 STAKEHOLDERS 14
2 RESEARCH METHODOLOGY 15
2.1 SECONDARY DATA 15
2.1.1 KEY DATA FROM SECONDARY SOURCES 16
2.2 PRIMARY DATA 16
2.2.1 KEY DATA FROM PRIMARY SOURCES 17
2.3 MARKET SIZE ESTIMATION 18
2.3.1 BOTTOM-UP APPROACH 18
2.3.2 TOP-DOWN APPROACH 19
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 20
2.5 ASSUMPTIONS FOR THE STUDY 21
3 EXECUTIVE SUMMARY 22
4 PREMIUM INSIGHTS 25
4.1 HEMOSTASIS VALVES: MARKET OVERVIEW 25
4.2 NORTH AMERICA: HEMOSTASIS VALVES MARKET, BY APPLICATION (2018) 26
4.3 GEOGRAPHICAL SNAPSHOT OF THE HEMOSTASIS VALVES MARKET 27
5 MARKET OVERVIEW 28
5.1 INTRODUCTION 28
5.2 MARKET DYNAMICS 28
5.2.1 DRIVERS 28
5.2.1.1 Increasing number of interventional procedures 28
5.2.2 OPPORTUNITIES 29
5.2.2.1 Emerging economies 29
5.2.2.2 Growth in the number of hospitals 29
 
6 HEMOSTASIS VALVES MARKET, BY TYPE 30
6.1 INTRODUCTION 31
6.2 HEMOSTASIS VALVE Y-CONNECTORS 33
6.2.1 HEMOSTASIS VALVE Y-CONNECTORS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE HEMOSTASIS VALVES MARKET DURING THE FORECAST PERIOD 33
6.3 DOUBLE Y-CONNECTOR HEMOSTASIS VALVES 34
6.3.1 DOUBLE Y-CONNECTOR HEMOSTASIS VALVES ARE THE FASTEST-GROWING SEGMENT OF THE ONE-HANDED HEMOSTASIS VALVES MARKET 34
6.4 ONE-HANDED HEMOSTASIS VALVES 34
6.4.1 SELF-CLOSING MECHANISM OF ONE-HANDED HEMOSTASIS VALVES
TO DRIVE ADOPTION 34
6.5 OTHER HEMOSTASIS VALVES 35
7 HEMOSTASIS VALVES MARKET, BY APPLICATION 36
7.1 INTRODUCTION 37
7.2 ANGIOGRAPHY 38
7.2.1 INCREASING NUMBER OF CORONARY ANGIOGRAPHY PROCEDURES
TO DRIVE MARKET GROWTH 38
7.3 ANGIOPLASTY 39
7.3.1 INCREASING BURDEN OF CORONARY HEART DISEASE TO DRIVE MARKET GROWTH 39
8 HEMOSTASIS VALVES MARKET, BY END USER 41
8.1 INTRODUCTION 42
8.2 HOSPITALS 43
8.2.1 ACCESS TO ADVANCED FACILITIES AND SKILLED PERSONNEL IS DRIVING PATIENT PREFERENCE FOR HOSPITAL CARE 43
8.3 OTHER END USERS 44
9 HEMOSTASIS VALVES MARKET, BY REGION 45
9.1 INTRODUCTION 46
9.2 NORTH AMERICA 47
9.2.1 US 49
9.2.1.1 Rising target disease incidence has aided the adoption of new technologies in the US 49
9.2.2 CANADA 51
9.2.2.1 Increasing number of PCI procedures 51
9.3 EUROPE 52
9.3.1 GERMANY 54
9.3.1.1 Increasing number of intervention procedures 54
9.3.2 UK 55
9.3.2.1 Rising geriatric population 55
 
9.3.3 FRANCE 56
9.3.3.1 Rising geriatric population 56
9.3.4 REST OF EUROPE 58
9.4 ASIA PACIFIC 60
9.4.1 CHINA 62
9.4.1.1 China will account for the largest share of the APAC market 62
9.4.2 INDIA 63
9.4.2.1 High prevalence of target diseases will ensure demand growth in India 63
9.4.3 JAPAN 65
9.4.3.1 CVD mortality has decreased in the country 65
9.4.4 REST OF ASIA PACIFIC 66
9.5 REST OF THE WORLD 68
10 COMPETITIVE LANDSCAPE 70
10.1 OVERVIEW 70
10.2 MARKET RANKING ANALYSIS, 2017 71
10.3 COMPETITIVE SCENARIO 72
10.3.1 ACQUISITIONS 72
10.3.2 EXPANSIONS 72
10.3.3 PRODUCT LAUNCHES 73
10.3.4 COLLABORATIONS 73
11 COMPANY PROFILES 74
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 BOSTON SCIENTIFIC 74
11.2 ABBOTT 76
11.3 MERIT MEDICAL SYSTEMS 79
11.4 TELEFLEX INCORPORATED 81
11.5 B. BRAUN MELSUNGEN AG 83
11.6 DEROYAL INDUSTRIES, INC. 85
11.7 TERUMO 86
11.8 ARGON MEDICAL 87
11.9 FREUDENBERG MEDICAL (A SUBSIDIARY OF FREUDENBERG GROUP) 88
11.10 SCITECH 90

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
 
12 APPENDIX 91
12.1 INSIGHTS OF INDUSTRY EXPERTS 91
12.2 DISCUSSION GUIDE 92
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 95
12.4 AVAILABLE CUSTOMIZATIONS 97
12.5 RELATED REPORTS 97
12.6 AUTHOR DETAILS 98